Despite widespread attention to the opioid overdose crisis, alcohol use continues to represent a pressing and under-recognized public health challenge.
Searching for Solutions
GLP-1RAs, traditionally prescribed for glycemic control in T2DM and weight management in obesity, are emerging as promising therapies for ASUDs.
Targeted efforts to enhance patient knowledge of MAUD could be a promising strategy for increasing medication uptake.
In this multicenter randomized clinical trial, RI had higher retention than SI overall and in patients who tested positive for fentanyl through extended-release buprenorphine injection 2.
Despite widespread health misinformation, 83% of patients still trust their doctors most for medical advice, up from 81% last year.
Clinicians should consider systematically assessing physical function in middle-aged patients who have polypharmacy, to capture physical decline earlier in the lifespan.
An umbrella review of nine systematic reviews published in BMJ shows no link between maternal acetaminophen (Tylenol) use during pregnancy and autism or attention deficit hyperactivity disorder (ADHD) in children.
To address provider cash-flow issues resulting from the expiration of Medicare telehealth flexibilities on Oct. 1, CMS announced Nov. 6 that they will return affected claims submitted on or before Nov. 10 and enable providers to resubmit them with expanded coding that clearly demonstrates eligibility under current law.
No summary available
No summary available
AAPP members Andrew Hean, PharmD, APh, BCPS, BCPP, and Winter Roth, PharmD, BCPP, authored this article in the Journal of the American College of Clinical Pharmacy.
Through expert guidance, participants will refine their presentation skills and learn how to captivate audiences. This 2-hour program with ACPE credit provides a unique opportunity to gain practical tools to elevate speaking abilities, enhance your expertise and confidence, and make you a standout voice in the field of psychiatric pharmacy. Don't miss this opportunity to learn!
The 2026 Physician Fee Schedule (PFS) final rule was released late last week by the Centers for Medicare and Medicaid (CMS). The rule makes direct supervision via telehealth permanent for many services. Additionally, it extends audio-only flexibilities for certain non-behavioral health visits through December 31, 2026. It also proposes new add-on codes for behavioral health integration services within Advanced Primary Care Management (APCM) programs.
AAPP joined more than 450 organizations in pushing congressional leaders to reinstate lapsed telehealth flexibilities for the long term. Lawmakers have been providing temporary extensions to telehealth policies that, among other flexibilities, allow Medicare beneficiaries to receive medical care in their homes. The policies started during the Covid-19 pandemic, and Congress continued them but never made them permanent.
No summary available
No summary available
No summary available
No summary available
No summary available
No summary available
Dr. Andrew C. Hean, 2023 Defining the Future grant recipient, and his co-authors Jamie Kneebusch,Casey Tiefenthaler, and Kelly C. Lee, recently had their research published! Dr. Hean said, "Thank you again to the foundation for making this research possible, a project that was quite special to me!" Congratulations to this research team, and thank you to our donors who make grants like this possible! You can now read and download the article online.
Approximately 13 percent of counties had more than half their population living in an area facing a pharmacy shortage last year, according to the National Community Pharmacists. The new data coincides with the NCPA and USC’s launch of the first public mapping tool tracking pharmacy shortage areas and closures over time by state, county and congressional district.
If you missed any of the previous Resident Journal Club presentations or would like to revisit a session, recordings are available for you to listen and review at your convenience. Once registered, you can access the recordings, presentations, and article links on the Journal Club page.
Gabapentin is approved by the U.S. Food and Drug Administration for treatment of partial seizures and postherpetic neuralgia, but is commonly prescribed for off-label use, including neuropathic pain.
Linkage to Care Outcomes Following Treatment in A Low-Threshold Substance Use Disorder Bridge Clinic
Of those participants who transitioned out of a bridge clinic into community-based SUD care, 78% were successfully connected to ongoing care and 84% were still in care at follow-up.